Stock Events

Stock Events

Organogenesis 

$1.6950
47
+$0.06+3.35% 16:01 Today

Statistics

Day High
1.705
Day Low
1.625
52W High
7.08
52W Low
1.54
Volume
5,575
Avg. Volume
-
Mkt Cap
218.1M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.71
-0.43
-0.16
0.12
Expected EPS
-0.17745
Actual EPS
N/A

Financials

3.55%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
564.17MRevenue
20.02MNet Income

Analyst Ratings

5.00Average Price Target
The highest estimate is 8.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ORGO. It's not an investment recommendation.
Apple
9
AAPL
Tesla
9
TSLA
Palantir Technologies
9
PLTR
Amazon
8
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Mimedx Group
MDXG
Mkt Cap655.92M
MiMedx Group, Inc. specializes in regenerative biomaterials and bioimplants, directly competing in the wound care and regenerative medicine space similar to Organogenesis.
Veru
VERU
Mkt Cap44.76M
Veru Inc. is involved in developing novel medicines for the management of breast cancer and sexually transmitted infections, competing in the healthcare solutions sector.
Biolife Solutions
BLFS
Mkt Cap1.78B
BioLife Solutions, Inc. provides bioproduction tools and services, including cell and gene therapy manufacturing, competing in the regenerative medicine supply chain.
Adma Biologics
ADMA
Mkt Cap2.09B
ADMA Biologics, Inc. specializes in the manufacture of plasma-derived biologics for immune deficiencies, competing in the broader biologics and regenerative medicine market.
Brainstorm Cell Therapeutics
BCLI
Mkt Cap11.92M
Brainstorm Cell Therapeutics Inc. focuses on developing adult stem cell therapies for neurodegenerative diseases, sharing the regenerative medicine market with Organogenesis.
KORU Medical Systems
KRMD
Mkt Cap149.14M
Repro Med Systems, Inc., doing business as KORU Medical Systems, provides home infusion solutions, indirectly competing by offering alternative medical treatment methods.
Sanara MedTech
SMTI
Mkt Cap317.63M
Sanara MedTech Inc. focuses on surgical and chronic wound care products, directly competing in the wound care market segment with Organogenesis.

About

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Show more...
CEO
Gary S. Gillheeney
Employees
854
Country
Cayman Islands
ISIN
US68621F1021
WKN
000A2PA31

Listings

STU
DE
2PQ.STU
XNAS
US
ORGO
MU
DE
2PQ.MU
BOATS
BOATS
ORGO.BOATS

0 Comments

Share your thoughts

FAQ

What is Organogenesis stock price today?▼
The current price of ORGO is $1.70 USD — it has increased by +3.35% in the past 24 hours. Watch Organogenesis stock price performance more closely on the chart.
What is Organogenesis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Organogenesis stocks are traded under the ticker ORGO.
Is Organogenesis stock price growing?▼
ORGO stock has fallen by -2.3% compared to the previous week, the month change is a -28.27% fall, over the last year Organogenesis has showed a -66.2% decrease.
What is Organogenesis market cap?▼
Today Organogenesis has the market capitalization of 218.1M
When is the next Organogenesis earnings date?▼
Organogenesis is going to release the next earnings report on November 05, 2026.
What were Organogenesis earnings last quarter?▼
ORGO earnings for the last quarter are -0.71 USD per share, whereas the estimation was -0.35 USD resulting in a -103.9% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Organogenesis revenue for the last year?▼
Organogenesis revenue for the last year amounts to 564.17M USD.
What is Organogenesis net income for the last year?▼
ORGO net income for the last year is 20.02M USD.
How many employees does Organogenesis have?▼
As of September 04, 2026, the company has 854 employees.
In which sector is Organogenesis located?▼
Organogenesis operates in the Health & Wellness sector.
When did Organogenesis complete a stock split?▼
Organogenesis has not had any recent stock splits.
Where is Organogenesis headquartered?▼
Organogenesis is headquartered in CANTON, Cayman Islands.